<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Graded</title><description>An independent guide to peptides, SARMs and substances sold for longer life</description><link>https://graded.pl/</link><item><title>The US health department published a draft policy under which it would not act against pharmacies that make BPC-157 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/bpc-157/</link><guid isPermaLink="true">https://graded.pl/en/substances/bpc-157/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>The US health department published a draft policy under which it would not act against pharmacies that make epitalon on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/epitalon/</link><guid isPermaLink="true">https://graded.pl/en/substances/epitalon/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>The US health department published a draft policy under which it would not act against pharmacies that make KPV on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/kpv/</link><guid isPermaLink="true">https://graded.pl/en/substances/kpv/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>The US health department published a draft policy under which it would not act against pharmacies that make MOTS-c on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/mots-c/</link><guid isPermaLink="true">https://graded.pl/en/substances/mots-c/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>The US health department published a draft policy under which it would not act against pharmacies that make semax on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/semax/</link><guid isPermaLink="true">https://graded.pl/en/substances/semax/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>The US health department published a draft policy under which it would not act against pharmacies that make TB-500 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.</title><link>https://graded.pl/en/substances/tb-500/</link><guid isPermaLink="true">https://graded.pl/en/substances/tb-500/</guid><pubDate>Fri, 30 Oct 2026 00:00:00 GMT</pubDate></item><item><title>WADA approved its list of banned substances for 2027, in force from 1 January 2027. Semaglutide and tirzepatide stay allowed.</title><link>https://graded.pl/en/changes/</link><guid isPermaLink="true">https://graded.pl/en/changes/</guid><pubDate>Thu, 10 Sep 2026 00:00:00 GMT</pubDate></item><item><title>FDA staff proposed that pharmacies should not make BPC-157. FDA advisers voted 8 to 6, with one abstention, to allow it. The vote is not binding.</title><link>https://graded.pl/en/substances/bpc-157/</link><guid isPermaLink="true">https://graded.pl/en/substances/bpc-157/</guid><pubDate>Thu, 23 Jul 2026 00:00:00 GMT</pubDate></item><item><title>The FDA announced a review of BPC-157 and other peptides. A law firm reports that they left a US list of substances raising concerns after requests were withdrawn. This does not mean pharmacies may legally make them.</title><link>https://graded.pl/en/substances/bpc-157/</link><guid isPermaLink="true">https://graded.pl/en/substances/bpc-157/</guid><pubDate>Thu, 16 Apr 2026 00:00:00 GMT</pubDate></item></channel></rss>